Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy
The purpose of this study is to validate a Patient Satisfaction Questionnaire for Anemia Treatment (PSQ-AT) in non small cell lung cancer patients treated with darbepoetin alfa or recombinant human erythropoietin (rHuEPO) for anemia due to chemotherapy.
Non-Small Cell Lung Cancer|Anemia
DRUG: darbepoetin alfa|DRUG: recombinant human erythropoietin (rHuEPO)
Anemia correction
Patient preference|Activities of daily living
The purpose of this study is to validate a Patient Satisfaction Questionnaire for Anemia Treatment (PSQ-AT) in non small cell lung cancer patients treated with darbepoetin alfa or recombinant human erythropoietin (rHuEPO) for anemia due to chemotherapy.